
A 39,669-patient French cohort found ustekinumab and IL-23 inhibitors carry the lowest infection risk among biologics.
Days before the U.S. Supreme Court is expected to rule on the constitutionality of the biggest overhaul of federal health care law in five decades, the nation's most powerful group of physicians said Saturday it may push for major changes — should the reforms land again in the hands of Congress.
While the fate of the Affordable Care Act hangs in the balance, American Medical Association President Dr. Peter Carmel argued that higher payments are needed for doctors who treat patients through the federal Medicare program.
Read the full story:
Source: Chicago Tribune





